• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A 型、B 型和非萎缩性胃炎]

[Type A, Type B, and Non-atrophic Gastritis].

作者信息

Lee Sun-Young

出版信息

Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):108-117. doi: 10.7704/kjhugr.2023.0015. Epub 2023 Jun 12.

DOI:10.7704/kjhugr.2023.0015
PMID:40502287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11967552/
Abstract

The gastric cancer risk varies based on the etiology and severity of gastritis, which depends on a history of infection and the secretory capacity of the stomach. Type A gastritis is associated with reverse atrophy of the corpus and type B with progressive atrophy extending from the antrum to the corpus. Diffuse or spotty redness in the corpus together with high serum pepsinogen (PG) II levels and a low PG I/II ratio are observed in patients with infection when secretory capacity of the stomach is intact. Diffuse-type gastric cancer may develop near the gastric folds, which is a rare site of atrophy. Low serum PG I levels are associated with progressive gastric corpus atrophy and intestinal metaplasia in patients with chronic and previous infections. This clinical scenario predisposes patients to intestinal-type gastric cancer, which originates in the atrophic and metaplastic gastric mucosa. Conversely, a high PG I/II ratio is observed in patients without infection. Serum PG I levels and the PG I/II ratio are high in patients with acute -negative gastritis, including drug-induced gastritis but are significantly low in autoimmune gastritis. Gastric neuroendocrine tumors may develop in patients with autoimmune gastritis or in those with long-term acid suppressant use. Fasting serum gastrin levels and the risk of neuroendocrine tumors are high in both cases. In this review, types of gastritis are summarized along with evaluation performed to determine the secretory capacity of the background gastric mucosa.

摘要

胃癌风险因胃炎的病因和严重程度而异,而胃炎的病因和严重程度取决于感染史和胃的分泌能力。A型胃炎与胃体部的逆向萎缩有关,B型胃炎则与从胃窦部延伸至胃体部的进行性萎缩有关。当胃的分泌能力完好时,感染患者会出现胃体部弥漫性或斑点状发红,同时血清胃蛋白酶原(PG)II水平升高,PG I/II比值降低。弥漫型胃癌可能在胃皱襞附近发生,这是一个罕见的萎缩部位。血清PG I水平低与慢性和既往感染患者的胃体部进行性萎缩及肠化生有关。这种临床情况使患者易患肠型胃癌,其起源于萎缩性和化生的胃黏膜。相反,未感染患者的PG I/II比值较高。急性幽门螺杆菌阴性胃炎患者(包括药物性胃炎)的血清PG I水平和PG I/II比值较高,但自身免疫性胃炎患者的该比值则显著降低。自身免疫性胃炎患者或长期使用抑酸剂的患者可能会发生胃神经内分泌肿瘤。在这两种情况下,空腹血清胃泌素水平和神经内分泌肿瘤的风险都很高。在本综述中,总结了胃炎的类型以及为确定背景胃黏膜分泌能力而进行的评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/df0feccd87cd/kjhugr-2023-0015f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/572664ee049f/kjhugr-2023-0015f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/91ffae24fc6b/kjhugr-2023-0015f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/4786dacc2499/kjhugr-2023-0015f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/077afc3bebea/kjhugr-2023-0015f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/3a6fd0ee9780/kjhugr-2023-0015f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/df0feccd87cd/kjhugr-2023-0015f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/572664ee049f/kjhugr-2023-0015f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/91ffae24fc6b/kjhugr-2023-0015f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/4786dacc2499/kjhugr-2023-0015f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/077afc3bebea/kjhugr-2023-0015f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/3a6fd0ee9780/kjhugr-2023-0015f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbb/11967552/df0feccd87cd/kjhugr-2023-0015f6.jpg

相似文献

1
[Type A, Type B, and Non-atrophic Gastritis].[A 型、B 型和非萎缩性胃炎]
Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):108-117. doi: 10.7704/kjhugr.2023.0015. Epub 2023 Jun 12.
2
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.美国胃肠病学会关于萎缩性胃炎诊断与管理的临床实践更新:专家综述
Gastroenterology. 2021 Oct;161(4):1325-1332.e7. doi: 10.1053/j.gastro.2021.06.078. Epub 2021 Aug 26.
3
The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.中国组织学胃炎分期-“OLGA/OLGIM”与血清胃蛋白酶原检测在评估胃萎缩/肠化生中的相关性
Scand J Gastroenterol. 2017 Aug;52(8):822-827. doi: 10.1080/00365521.2017.1315739. Epub 2017 Apr 22.
4
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.基于血清胃蛋白酶原和幽门螺杆菌抗体滴度评估的慢性活动性胃炎和由此导致的胃萎缩与癌症发展的关系。
Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3.
5
Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.内镜下胃炎、血清胃蛋白酶原检测及幽门螺杆菌感染
Korean J Intern Med. 2016 Sep;31(5):835-44. doi: 10.3904/kjim.2016.166. Epub 2016 Sep 1.
6
Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.血清生物标志物检测有助于区分胃萎缩患者与正常健康的胃部情况。
World J Gastroenterol. 2009 Feb 21;15(7):853-9. doi: 10.3748/wjg.15.853.
7
Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.幽门螺杆菌根除后长期监测中血清胃蛋白酶原和胃泌素的改善:与幽门螺杆菌阴性患者的比较。
Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:25-32. doi: 10.1111/j.1365-2036.2004.01970.x.
8
Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.血浆胃饥饿素浓度与血清胃蛋白酶原I水平及胃蛋白酶原I/II比值相关——一种可能的新型非侵入性胃萎缩标志物。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1249-54.
9
Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.萎缩性胃炎患者血清中酰胺化胃泌素-17和胃蛋白酶原I水平:一项观察性病例对照研究。
Scand J Gastroenterol. 2002 Jul;37(7):785-91.
10
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.根除治疗前后幽门螺杆菌感染的萎缩性胃黏膜中鸟氨酸脱羧酶、环氧化酶-2和胃泌素的基因表达
Dig Dis Sci. 2003 Jan;48(1):36-46. doi: 10.1023/a:1021774029089.

引用本文的文献

1
A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels.一项利用胃蛋白酶原和胃泌素-17水平检测胃肿瘤的前瞻性研究。
Gut Liver. 2025 Jul 15;19(4):548-558. doi: 10.5009/gnl240544. Epub 2025 Apr 11.

本文引用的文献

1
Regression of Autoimmune Gastritis after Eradication of .根除幽门螺杆菌后自身免疫性胃炎的消退 。 你提供的原文不完整,“of”后面缺少内容。以上是根据已有信息尽量完整的翻译。
Case Rep Gastroenterol. 2023 Jan 10;17(1):34-40. doi: 10.1159/000528388. eCollection 2023 Jan-Dec.
2
Changes in gastric morphology during long-term use of vonoprazan compared to proton pump inhibitors.与质子泵抑制剂相比,长期使用沃克唑胺期间胃形态的变化。
Singapore Med J. 2022 May;63(5):283-287. doi: 10.11622/smedj.2022076.
3
Evaluation of screening tests for autoimmune gastritis in histopathologically confirmed Japanese patients, and re-evaluation of histopathological classification.
评估组织病理学确诊的日本患者自身免疫性胃炎的筛查试验,并重新评估组织病理学分类。
BMC Gastroenterol. 2022 Apr 11;22(1):179. doi: 10.1186/s12876-022-02251-8.
4
Useful Serum Pepsinogen Levels for Detecting Ongoing Helicobacter pylori Infection in Asymptomatic Subjects: A Cross-Sectional Study Based on C-urea Breath Test Findings.基于 C-尿素呼气试验结果的一项横断面研究:用于检测无症状人群中持续性幽门螺杆菌感染的有用血清胃蛋白酶原水平。
Dig Dis Sci. 2022 Dec;67(12):5602-5609. doi: 10.1007/s10620-022-07471-2. Epub 2022 Apr 6.
5
Effects of Proton Pump Inhibitor Therapy, Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations.质子泵抑制剂治疗、感染和胃前瘤病变对空腹血清胃泌素浓度的影响。
Front Endocrinol (Lausanne). 2021 Nov 18;12:741887. doi: 10.3389/fendo.2021.741887. eCollection 2021.
6
Eosinophilic Gastrointestinal Diseases: The Pathogenesis, Diagnosis, and Treatment.嗜酸性粒细胞性胃肠道疾病:发病机制、诊断和治疗。
Intern Med. 2023 Jan 1;62(1):1-10. doi: 10.2169/internalmedicine.8417-21. Epub 2021 Oct 19.
7
Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: A cross-sectional study.内镜京都胃炎分类与胃炎病理学悉尼系统更新版之间的一致性:一项横断面研究。
J Gastroenterol Hepatol. 2022 Feb;37(2):291-300. doi: 10.1111/jgh.15693. Epub 2021 Oct 6.
8
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.美国胃肠病学会关于萎缩性胃炎诊断与管理的临床实践更新:专家综述
Gastroenterology. 2021 Oct;161(4):1325-1332.e7. doi: 10.1053/j.gastro.2021.06.078. Epub 2021 Aug 26.
9
Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.肠嗜铬样细胞增生相关胃神经内分泌肿瘤可能与质子泵抑制剂的使用有关。
Arch Pathol Lab Med. 2022 Mar 1;146(3):366-371. doi: 10.5858/arpa.2020-0315-OA.
10
Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia.吡仑帕奈对沃诺拉赞引起的胃酸抑制和高胃泌素血症的影响。
Eur J Clin Pharmacol. 2021 Jul;77(7):971-978. doi: 10.1007/s00228-021-03162-5. Epub 2021 May 31.